Myconostica Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Myconostica General Information

Description

Developer of molecular diagnostic fungal testing products designed to aid rapid and accurate diagnosis of life-threatening invasive fungal infections. The company offers molecular tests to identify infected patients, thereby helping clinicians to prescribe appropriate drug therapy and increase the chances of survival of those patients.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Microgen Bioproducts 1 Admiralty Way
  • Camberley GU15 3DT
  • England, United Kingdom
+44 01276
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • Microgen Bioproducts 1 Admiralty Way
  • Camberley GU15 3DT
  • England, United Kingdom
+44 01276

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Myconostica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 23-May-2011 Completed Generating Revenue
5. Later Stage VC (Series D) 19-Jul-2010 Completed Generating Revenue
4. Early Stage VC 09-Apr-2008 Completed Product Development
3. Early Stage VC 30-Jul-2007 Completed Product Development
2. Early Stage VC 27-Nov-2006 $1.91M $1.91M Completed Product Development
1. University Spin-Out 01-Jan-2006 Completed Startup
To view Myconostica’s complete valuation and funding history, request access »

Myconostica Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
D Preference
C Preference
Ordinary 250 $0.015101 $60.4 $60.4 1x $60.4 0%
B Preference 54,545 $0.015101 $27.69 $27.69 1x $27.69 0.53%
To view Myconostica’s complete cap table history, request access »

Myconostica Patents

Myconostica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201005622-D0 Assay for candida glabrata Inactive 01-Apr-2010
WO-2011121288-A2 Assays for candida glabrata Inactive 29-Mar-2010
WO-2011121288-A3 Assays for candida glabrata Inactive 29-Mar-2010
GB-0918926-D0 Assay Inactive 28-Oct-2009
WO-2011030091-A1 Assay for candida species Inactive 11-Sep-2009 C12Q1/6816
To view Myconostica’s complete patent history, request access »

Myconostica Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Myconostica Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amphion Innovations Venture Capital Minority
IPSA( Asset Management) Venture Capital Minority
MTI Partners Venture Capital Minority
Medac Pharma Corporation Minority
Medicis Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Myconostica FAQs

  • When was Myconostica founded?

    Myconostica was founded in 2006.

  • Where is Myconostica headquartered?

    Myconostica is headquartered in Camberley, United Kingdom.

  • What is the size of Myconostica?

    Myconostica has 13 total employees.

  • What industry is Myconostica in?

    Myconostica’s primary industry is Diagnostic Equipment.

  • Is Myconostica a private or public company?

    Myconostica is a Private company.

  • What is Myconostica’s current revenue?

    The current revenue for Myconostica is .

  • How much funding has Myconostica raised over time?

    Myconostica has raised $10.6M.

  • Who are Myconostica’s investors?

    Amphion Innovations, IPSA( Asset Management), MTI Partners, Medac Pharma, and Medicis Capital are 5 of 6 investors who have invested in Myconostica.

  • When was Myconostica acquired?

    Myconostica was acquired on 23-May-2011.

  • Who acquired Myconostica?

    Myconostica was acquired by Cambridge Clinical Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process